PASW Ping An Biomedical Co., Ltd.
Price Chart
Executive Summary
Ping An Biomedical received a Nasdaq letter on May 26, 2026, granting an additional 180-day compliance period (until November 23, 2026) to regain the $1 minimum bid price. The company remains non-compliant and is evaluating a reverse stock split as a potential cure, but there is no guarantee of success.
Actionable Insight
Monitor the stock's bid price closely ahead of the November 23, 2026 deadline. A reverse stock split announcement could provide a temporary boost, but failure to maintain compliance would lead to delisting and potential loss of liquidity. Consider reducing exposure given the high delisting risk.
Key Facts
- Nasdaq notified the company on November 24, 2025, of bid price non-compliance under Rule 5550(a)(2).
- On May 26, 2026, Nasdaq granted an additional 180-day period until November 23, 2026, to regain compliance.
- The company must maintain a closing bid price of at least $1 for 10 consecutive business days to cure.
- The company intends to use a reverse stock split if necessary, but there is no assurance of regaining compliance.
- Market cap is $19M, indicating a micro-cap with significant delisting risk.
Financial Impact
Delisting risk persists; no financial figures provided in the filing.
Risk Factors
- Failure to regain compliance by November 23, 2026, could result in Nasdaq delisting.
- Reverse stock split may not achieve sustained compliance and could further depress the stock.
- Low market cap ($19M) and ongoing non-compliance signal financial distress.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-061559 |
| Document: 0001213900-26-061559-index-headers.html | 0001213900-26-061559 |
| Document: 0001213900-26-061559-index.html | 0001213900-26-061559 |
| Document: 0001213900-26-061559.txt | 0001213900-26-061559 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 27, 2026
16d ago
|
6-K
| $0.1560 $0.1780 | ▼ −14.10% | ▼ −13.79% | $0.1670 (−7.05%) |
|
Feb 27, 2026
15w ago
|
EFFECT
| $0.1490 $0.1480 | ▼ −0.67% | ▲ +1.31% | $0.1670 (+12.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access